Welcome to our dedicated page for Nano Dimension Ltd. SEC filings (Ticker: NNDM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Nano Dimension Ltd.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Nano Dimension Ltd.'s regulatory disclosures and financial reporting.
Oramed Pharmaceuticals Inc., a Delaware corporation, updated its Schedule 13D regarding Nano Dimension Ltd. ordinary shares. Oramed now beneficially owns 6,879,708 shares with sole voting and dispositive power, representing 3.3% of the class, based on 210,506,899 shares outstanding as of June 23, 2026.
On July 20, 2026, Oramed executed a block sale of 8,200,000 Nano Dimension shares at $1.55 per share and spent approximately $1,258,000 to purchase call options referencing an aggregate of 8,200,000 shares. It also bought call options over 1,350,000 shares at $1.50 expiring August 21, 2026, and 6,850,000 shares at $2.00 expiring November 20, 2026, and sold put options over 8,200,000 shares in total. Oramed reports that it ceased to beneficially own more than five percent of the outstanding shares on July 20, 2026 and is no longer party to any options contracts on Nano Dimension shares.
Nano Dimension Ltd. entered into a Settlement Agreement on July 17, 2026 with its directors and shareholder Murchinson Ltd., under which four directors (Robert Pons, David Stehlin, Dr. Joshua Rosensweig and Andrew Sriubas) resigned and three Murchinson-nominated directors (Pinchos (Paul) Fruchthandler, Moshe Rozenbaum and Eliezer Eli Tarlow) were appointed, resulting in a change in control of the company. Murchinson irrevocably withdrew its May 21, 2026 demand for an extraordinary general meeting, and the July 31, 2026 meeting was cancelled. The agreement also includes mutual releases, covenants not to pursue certain legal proceedings, and non-disparagement provisions.
In connection with the settlement, the departing directors’ resignations, including that of CEO David Stehlin, became effective immediately after execution and were stated not to be due to any disagreement over operations, policies or practices. On July 21, 2026, new director Moshe Rozenbaum, age 44 and a former VP – Corporate Development of Nano Dimension, was appointed Interim CEO. The board designated Fruchthandler and Tarlow as independent under Nasdaq rules, added both to the Audit and Compensation Committees, and appointed Mr. Borenstein as Chair of the Board.
Nano Dimension Ltd. entered into an agreement to terminate the lease for its current corporate headquarters, effective December 31, 2026, as part of broader cost savings initiatives. The long-term lease was originally signed in 2021 by MarkForged, Inc. and scheduled to run through 2031.
The company expects the termination to eliminate approximately $38 million of cumulative future lease costs through 2031. After an approximately $13 million lease termination payment, Nano Dimension projects about $25 million in cumulative net cash savings.
Separately, the previously announced sale of MarkForged, Inc. was expected to reduce annualized cash burn by approximately $15 million, including about $7.5 million of annualized lease-related savings. Management states that these actions reflect a disciplined approach to capital allocation and focus on streamlining operations, reducing cash burn and strengthening the financial position.
Murchinson Ltd., Nomis Bay Ltd., BPY Ltd., EOM Management Ltd. and several individuals report updated beneficial ownership of American Depositary Shares of Nano Dimension Ltd. Each Share represents one Ordinary Share. Murchinson Ltd. and Marc J. Bistricer each report beneficial ownership of 17,136,276 Shares, representing 8.1% of the class, based on 210,506,899 Shares outstanding as of June 23, 2026.
Nomis Bay holds 5,148,731 Shares (2.4%) acquired for approximately $14,705,420 plus $270,000 in depositary fees, BPY holds 3,419,407 Shares (1.6%) for approximately $9,785,746 plus $30,000 in fees, and Managed Positions hold 8,568,138 Shares for approximately $24,491,023 plus $562,500 in fees. On July 17, 2026, the reporting persons and Nano Dimension entered a Settlement Agreement under which four directors resigned, three new directors were appointed through the 2026 annual meeting, the investors withdrew their demand for an extraordinary general meeting, and the parties agreed to mutual releases, litigation-related covenants and non-disparagement provisions.
Nano Dimension Ltd. reported that Chief Executive Officer David Stehlin had 24,971 ordinary shares withheld on July 13, 2026 at $1.4800 per share. The issuer retained these shares to satisfy tax withholding obligations associated with the vesting of restricted stock units. Following this tax-withholding disposition, Stehlin directly holds 737,032 ordinary shares.
David Stehlin has notified of a proposed sale of up to 24,971 Nano Dimension Ltd. American Depositary Shares representing Ordinary Shares through Oppenheimer & Co. Inc. on or about July 13, 2026, to be traded on Nasdaq. The securities were issued upon vesting of restricted stock units, with 578,703 shares issued at no cash consideration. Over the prior three months, he sold 18,276, 19,832, and 19,841 ADSs on April 27, May 11, and June 9, 2026, for aggregate prices of $33,108.80, $31,735.17, and $30,207.92, respectively.
Tang Capital Management and related entities filed a Schedule 13D on Nano Dimension Ltd., disclosing beneficial ownership of 14,292,813 Ordinary Shares, equal to 6.8% of the company. These shares are held as American Depository Shares, each representing one Ordinary Share.
The filing states that approximately $19.5 million of working capital from various Tang Capital funds was used to acquire the position. On June 30, 2026, Tang Capital Management sent Nano Dimension a merger proposal involving an affiliate of the reporting group. The proposal is non-binding and subject to limited confirmatory diligence and negotiation of a definitive merger agreement, and there is no assurance discussions will occur or lead to a transaction.
Murchinson Ltd. and affiliated investors filed Amendment No. 17 to their Schedule 13D on Nano Dimension Ltd., updating their ownership and group arrangements. The filing shows aggregate beneficial ownership of 20,285,450 American Depositary Shares by Murchinson and 20,285,450 ADS by Marc J. Bistricer, each representing 9.6% of the 210,354,507 Shares outstanding as of May 27, 2026. Nomis Bay Ltd. reports 6,093,483 Shares (2.9%), BPY Ltd. reports 4,049,242 Shares (1.9%), and EOM Management Ltd. reports 10,142,725 Shares (4.8%), largely through managed positions. The amendment details that these positions were bought with working capital, provides approximate aggregate purchase prices and ADS conversion fees, and formalizes a Joint Filing Agreement among nine reporting persons.